Company Filing History:
Years Active: 2004-2014
Title: Douglas E. Skilling: Innovator in Antiviral Solutions
Introduction
Douglas E. Skilling, an esteemed inventor based in Corvallis, OR, has made significant contributions to the field of antiviral research. With two patents to his name, his work focuses on innovative solutions for treating viral infections, showcasing his commitment to advancing medical science.
Latest Patents
One of Skilling’s notable patents is related to an antisense antiviral agent and method for treating ssRNA viral infections. This invention provides antisense antiviral compounds and methods for inhibiting the growth of viruses from the picornavirus, calicivirus, togavirus, and flavivirus families. The compounds feature morpholino subunits linked by uncharged phosphorodiamidate linkages interspersed with cationic phosphorodiamidate linkages. Furthermore, his invention emphasizes the significance of targeting viral sequences with oligomers that are substantially uncharged, which complement the viral target sequences.
Career Highlights
Throughout his career, Douglas E. Skilling has been affiliated with notable companies in the biotech industry, including Avi Biopharma, Inc. and Sarepta Therapeutics, Inc. His work in these organizations has propelled advancements in therapeutic approaches and antiviral treatments.
Collaborations
Skilling has collaborated with other experts in the field, including colleagues David A. Stein and Patrick L. Iversen. These collaborations have significantly influenced his research and the resulting innovations, reflecting the power of teamwork in scientific discoveries.
Conclusion
Douglas E. Skilling's contributions to antiviral research underscore his role as a pioneering inventor in the medical field. His innovative approaches and successful patents not only demonstrate his expertise but also pave the way for future advancements in treating viral infections. As our understanding of viruses continues to evolve, inventors like Skilling are crucial in developing effective solutions to combat viral diseases.